Our Member of the Week blog introduces you to our fellow level members, showcasing their unique work and commitment to IOF. We feature different fellows who have made extraordinary contributions to the field of Interventional Orthopedics.
To be considered for this feature, please email us.
Connect with Dr. Bodor
Meet Dr. Bodor
Our latest IOF Member of the Week feature takes us to California to meet Marko Bodor, MD who is doing incredible work regarding common neuromuscular and musculoskeletal diseases.
Dr. Bodor has an interventional spine and sports medicine practice in Napa, California and has had a fellowship program since 2004. Dr. Bodor has expertise in diagnostic and interventional ultrasound and regenerative medicine and has developed techniques for ultrasound-guided carpal tunnel release, cervical facet and disc injections.
Additionally, Dr. Bodor has a research foundation whose goal is to develop regenerative medicine techniques to cure common neuromuscular and musculoskeletal diseases.
Q&A with Dr. Bodor
IOF: How has IOF impacted you the most?
Dr. Bodor: IOF has provided a forum and meeting place for like-minded specialists whose primary goal is to treat problems rather than symptoms, for instance the cause of pain rather than pain pathways.
What do you like the best about the IOF conference?
I most look forward to seeing colleagues and having informal discussions one-on-one or at social gatherings.
Who are your biggest mentors in regenerative medicine and why?
My biggest mentors in regenerative medicine would have to be Arnold Caplan and Chris Centeno. Arnold has laid the groundwork in the lab for the many things we are doing, while Chris was among the first to develop many of the treatments we are using in the clinical setting.
What do you treat most frequently with regenerative medicine?
I treat the spine most frequently, discs and facets, followed by shoulders, knees and hips, but we really treat everything, from head to toes.
Where do you see the field of regenerative medicine going in the next five years?
I see more randomized controlled trials proving the efficacy of these treatments for discrete conditions, such as discs and meniscus tears. I also envision improvement in our ability to treat osteoarthritis, which remains difficult.
What do you most look forward to when attending an IOF event?
I like the fun people and atmosphere. It’s a great combination of innovation and solid grounding in traditional medical science.